 |
| antimicrobial catheter market |
The antimicrobial catheter market comprises catheters coated or impregnated
with antimicrobial agents to prevent the risk of catheter-associated urinary
tract infections. Catheter associated urinary tract infections are one of the
most common hospital acquired infections. The growing geriatric population who
are at high risk of urinary tract diseases and the increasing number of
surgical procedures propel the demand for antimicrobial catheters. Catheters
integrated with antimicrobial agents such as silver, minerals and antibiotics
prevent the attachment and proliferation of microbes on catheter surfaces. The
rising focus on reducing the healthcare costs of treating hospital acquired
infections drives the adoption of antimicrobial catheters.
The
Global Antimicrobial Catheter Market Size is estimated to be valued at US$ 14505.18 Mn in 2024 and is expected
to exhibit a CAGR of 11% over the
forecast period 2024 to 2031.
Key Takeaways
Key players operating in the antimicrobial catheter market are Pendulum,
Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences,
TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next
Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. Pendulum captured
a significant market share owing to its wide portfolio of silver alloy coated
catheters.
The rising incidence of multidrug resistance presents an opportunity for
companies to invest in R&D of novel antimicrobial agents. Efforts to reduce
the treatment costs of catheter associated infections will further drive the
clinical adoption of antimicrobial catheters.
Key market players are focusing on expanding their geographical presence in
high growth regions such as Asia Pacific and Middle East Africa. Partnerships
with major healthcare providers and regulatory approvals help fast track market
access.
Market Drivers
Growing geriatric population: The aging population is more prone to diseases
requiring long term catheterization and are at elevated risk of urinary tract
infections. It is estimated that over 70% of all catheter associated infections
occur in patients aged above 65 years.
Rising healthcare costs: Catheter associated urinary tract infections lead to
increased hospital readmissions, longer hospitalization periods and higher
medical costs. The use of antimicrobial catheters helps reduce the clinical and
economic burden to some extent.
Market Restraints
Limitations of coating technologies: Leaching and phase separation issues can
compromise the efficacy of antimicrobial coatings over extended usage periods.
Alternative modalities such as impregnation overcome these constraints but
increase production costs.
Regulatory compliance: Regulators scrutinize the safety and performance
requirements for antimicrobial medical devices more stringently. Obtaining
favorable regulatory clearances is a lengthy and expensive process limiting
market entries.
Segment Analysis
The urinary catheter segment is dominating the antimicrobial catheter market as
these are widely used during urinary tract infections and other surgeries of
urinary tract. The segment accounts for over 35% of total market share owing to
high adoption rate.
Global Analysis
North America is the fastest growing region in the antimicrobial catheter
market. It accounts for around 40% of the total market share and is expected to
continue its dominance during the forecast period. High prevalence of hospital
acquired infections and urinary tract infections in countries like the US is
supporting market growth. Besides strong reimbursement policies are also
encouraging adoption of advanced antimicrobial technology in this region. Asia
Pacific is also expected to witness significant growth owing to improving
healthcare infrastructure and rising medical tourism in countries like India
and China.
Get More
Insights On This Topic: Antimicrobial
Catheter Market
Explore More Related Topic: Biochips
Market